Fred Hsieh, MD

• Program Director, Allergy and Immunology Fellowship Training Program
• Vice-Chair, Allergy and Immunology
• Fellow, American College of Allergy, Asthma, and Immunology
• Fellow, American Academy of Allergy, Asthma, and Immunology
• past Associate Editor and Editorial Board Member, Annals of Allergy, Asthma, and Immunology
• ad hoc reviewer: American Journal of Physiology: Lung Cellular and Molecular Physiology; Respiratory Research; Cleveland Clinic Journal of Medicine; American Journal of Respiratory and Critical Care Medicine; Journal of Pediatrics; Journal of Experimental Medicine; Proceedings of the National Academy of Sciences USA; Journal of Allergy and Clinical Immunology; American Journal of Respiratory Cell and Molecular Biology; Journal of Immunology; Allergy; Journal of Bronchology; Journal of Vascular Research
• ad hoc grant reviewer: University Grants Committee, Research Grants Council of Hong Kong; American Institute of Biological Sciences-FAMRI; National Heart Lung and Blood Institute, National Institutes of Health; Clinical and Translational Science Collaborative-Clinical and Translational Science Award Program, Case Western Reserve University; Leukemia and Lymphoma Research UK-Northern Ireland; Asthma UK.

• Sigma Xi
• Howard Hughes Medical Institute Research Training Fellowship
• American Academy of Allergy, Asthma, and Immunology Respiratory Diseases
• Research Award, Glaxo-Wellcome Allergy Fellowship Award 
• Allergy and Immunology Teacher of the Year
• Best Doctors, Allergy and Immunology, Adult, 2009-present
•  

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-03-17, Dr. Hsieh has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.